Status:
COMPLETED
Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Collaborating Sponsors:
Apollo Medical Optics, Ltd
Conditions:
Amyloidosis
Eligibility:
All Genders
20+ years
Brief Summary
Amyloidosis is caused by the misfolding protein accumulated in tissue, which affects the function of the organs. In addition to the primary cutaneous amyloidosis, a skin lesion may also appear in anot...
Eligibility Criteria
Inclusion
- Patients diagnosed with suspected primary cutaneous amyloidosis and other indistinguishable diseases
- Patients with no open wounds
Exclusion
- Patients with a transcutaneous infectious disease
- Patients under the age of 20
- Vulnerable populations, including: pregnant women, handicapped, and homelessness
- Patient cannot cooperate in examination
Key Trial Info
Start Date :
March 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04068077
Start Date
March 8 2019
End Date
December 19 2019
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Beitou District, Taiwan, 11217